Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection

Objectives Innate lymphoid cells (ILCs) share many characteristics with CD4+ T cells, and group 1 ILCs share a requirement for T‐bet and the ability to produce IFNγ with T helper 1 (Th1) cells. Given this similarity, and the importance of Th1 cells for protection against intracellular protozoan para...

Full description

Saved in:
Bibliographic Details
Published inClinical & translational immunology Vol. 7; no. 1; pp. e1003 - n/a
Main Authors Ng, Susanna S, Souza‐Fonseca‐Guimaraes, Fernando, Rivera, Fabian de Labastida, Amante, Fiona H, Kumar, Rajiv, Gao, Yulong, Sheel, Meru, Beattie, Lynette, Montes de Oca, Marcela, Guillerey, Camille, Edwards, Chelsea L, Faleiro, Rebecca J, Frame, Teija, Bunn, Patrick T, Vivier, Eric, Godfrey, Dale I, Pellicci, Daniel G, Lopez, J Alejandro, Andrews, Katherine T, Huntington, Nicholas D, Smyth, Mark J, McCarthy, James, Engwerda, Christian R
Format Journal Article
LanguageEnglish
Published Australia John Wiley & Sons, Inc 2018
Nature Publishing Group
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN2050-0068
2050-0068
DOI10.1002/cti2.1003

Cover

More Information
Summary:Objectives Innate lymphoid cells (ILCs) share many characteristics with CD4+ T cells, and group 1 ILCs share a requirement for T‐bet and the ability to produce IFNγ with T helper 1 (Th1) cells. Given this similarity, and the importance of Th1 cells for protection against intracellular protozoan parasites, we aimed to characterise the role of group 1 ILCs during Plasmodium infection. Methods We quantified group 1 ILCs in peripheral blood collected from subjects infected with with Plasmodium falciparum 3D7 as part of a controlled human malaria infection study, and in the liver and spleens of PcAS‐infected mice. We used genetically‐modified mouse models, as well as cell‐depletion methods in mice to characterise the role of group 1 ILCs during PcAS infection. Results In a controlled human malaria infection study, we found that the frequencies of circulating ILC1s and NK cells decreased as infection progressed but recovered after volunteers were treated with antiparasitic drug. A similar observation was made for liver and splenic ILC1s in P. chabaudi chabaudi AS (PcAS)‐infected mice. The decrease in mouse liver ILC1 frequencies was associated with increased apoptosis. We also identified a population of cells within the liver and spleen that expressed both ILC1 and NK cell markers, indicative of plasticity between these two cell lineages. Studies using genetic and cell‐depletion approaches indicated that group 1 ILCs have a limited role in antiparasitic immunity during PcAS infection in mice. Discussion Our results are consistent with a previous study indicating a limited role for natural killer (NK) cells during Plasmodium chabaudi infection in mice. Additionally, a recent study reported the redundancy of ILCs in humans with competent B and T cells. Nonetheless, our results do not rule out a role for group 1 ILCs in human malaria in endemic settings given that blood stage infection was initiated intravenously in our experimental models, and thus bypassed the liver stage of infection, which may influence the immune response during the blood stage. Conclusion Our results show that ILC1s are lost early during mouse and human malaria, and this observation may help to explain the limited role for these cells in controlling blood stage infection. In a controlled human malaria infection study, we found that the frequencies of circulating ILC1s and NK cells decreased as infection progressed, but recovered after volunteers were treated with antiparasitic drug. A similar observation was made for liver and splenic ILC1s in P. chabaudi chabaudi AS (PcAS)‐infected mice. Studies using genetic and cell‐depletion approaches indicated that group 1 ILCs have a limited role in antiparasitic immunity during PcAS infection in mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
This work was made possible through Queensland State Government funding. The research was supported by grants and fellowships from the National Health and Medical Research Council of Australia (NHMRC) and Australia Research Council (ARC), as well as Australian Postgraduate Awards through Griffith University, School of Natural Sciences and the University of Queensland, School of Medicine and an INSPIRE Fellowship to Rajiv Kumar provided by the Indian government Department of Science and Technology. Funding for the CHMI studies was provided by Medicines for Malaria Venture (MMV) from grants awarded by the Wellcome Trust and Bill and Melinda Gates Foundation
These authors contributed equally to the work.
ISSN:2050-0068
2050-0068
DOI:10.1002/cti2.1003